School of Medicine
Showing 1-100 of 169 Results
-
Bruce T. Adornato
Adjunct Clinical Professor, Neurology & Neurological Sciences
BioDr. Adornato joined the Department of Neurology as Voluntary Clinical Faculty in 1978, (subsequently Adjunct Clinical Faculty) and has served as Director of the Neuromuscular Laboratory from 1978 until 1983, performing and interpreting nerve and muscle biopsies as well as serving as attending physician directing residents and medical students in the diagnosis and care of his private patients admitted to Stanford Hospital. Since 1986, he has been attending physician at the Palo Alto VA Hospital, directing Stanford Neurology residents and medical students in the care of veterans. He has published 69 peer reviewed papers and a number of book chapters in the field of neurology. He is currently the medical officer of a silicon valley startup exploring mobility devices for the neurologically impaired.
-
Gregory W. Albers, MD
Coyote Foundation Professor and Professor, by courtesy, of Neurosurgery
On Partial Leave from 04/01/2022 To 11/30/2022Current Research and Scholarly InterestsOur group's research focus is the acute treatment and prevention of cerebrovascular disorders. Our primary interest is the use of advanced imaging techniques to expand the treatment window for ischemic stroke. We are also conducting clinical studies of both neuroprotective and thrombolytic strategies for the treatment of acute stroke and investigating new antithrombotic strategies for stroke prevention.
-
Katrin Andreasson
Professor of Neurology
Current Research and Scholarly InterestsOur research focuses on understanding how immune responses initiate and accelerate synaptic and neuronal injury in age-related neurodegeneration, including models of Alzheimer's disease and Parkinson's disease. We also focus on the role of immune responses in aggravating brain injury in models of stroke. Our goal is the identification of critical immune pathways that function in neurologic disorders and that can be targeted to elicit disease modifying effects.
-
Meredith Barad, MD
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
Clinical Associate Professor, Neurology & Neurological SciencesCurrent Research and Scholarly InterestsMy current research interests involve novel treatment paradigms for challenging pain problems such as orofacial pain, trigeminal neuralgia and low pressure headaches. I am also interested in migraine and trigeminal autonomic cephalgias and their intersection with chronic pain.
-
Fiona Baumer
Assistant Professor of Neurology and of Pediatrics
Current Research and Scholarly InterestsCauses of Disturbed Cognition in Pediatric Epilepsy
-
Michael Eddy F Belloy
Instructor, Neurology & Neurological Sciences
BioMy broad scientific goal is to investigate neurological disorders with the aim of identifying novel mechanisms that improve understanding of disease pathophysiology and that could lead to novel drug development. I pursue this goal by investigating the genetic risk factors of the respective disease under question, studying how they contribute to disruptions of brain function measured by in vivo imaging techniques, and how they correlate with the presentation of disease-sensitive biomarkers. Within this broader scope, my primary interest is to focus specifically on Alzheimer's disease, elucidating the genetic, molecular, and clinical spectrum of the disease, and hopefully, eventually, contributing to the path towards a cure.
I am a highly interdisciplinary scientist with experience in programming (using various scripting languages), advanced data analyses methods, neuroimaging, and studies of preclinical mouse models of Alzheimer’s disease. I also have a long-standing interest in brain function and network dynamics in both health and disease. During my postdoc at Stanford, I have further gained experience into the clinical aspects, imaging approaches, and genetics of Alzheimer’s disease. Altogether, this translates into my current research strategy in which I investigate large-scale multimodal datasets that contain information on genetics, multi-omics, clinical outcome measures, structural and functional brain properties, and other biomarker data.
I am currently an Instructor at Stanford university, in the lab of Dr. Michael D Greicius. My main aims in this lab are to identify genetic factors that may be causative to Alzheimer's disease. Specifically, I aim to uncover genetic risk factors that interact with the Apolipoprotein E (APOE) gene or sex to alter risk for Alzheimer’s disease. Furthermore, I seek to identify how genetic risk associations differ across the intersection of APOE, sex, age, and genetic ancestry. I believe this will allow the identification of novel genes relevant to Alzheimer's disease and contribute to advancing personalized genetic medicine.
During my PhD, supervised by Dr. Marleen Verhoye, Dr. Shella Keilholz and Dr. Georgios A Keliris, I worked on developing dynamic resting state functional (rsf)MRI in mice, which lead to the first observation of mouse Quasi-Periodic patterns, and related applications for Alzheimer's disease research in rodents. I still have an ongoing interest in dynamic rsfMRI research. -
Helen Bronte-Stewart, MD, MS
John E. Cahill Family Professor, Professor of Neurology and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsMy research focus is human motor control and brain pathophysiology in movement disorders. Our overall goal is to understand the role of the basal ganglia electrical activity in the pathogenesis of movement disorders. We have developed novel computerized technology to measure fine, limb and postural movement. With these we are measuring local field potentials in basal ganglia nuclei in patients with Parkinson's disease and dystonian and correlating brain signalling with motor behavior.
-
Martin Brown
Professor of Radiation Oncology, Emeritus
Current Research and Scholarly InterestsWe seek to understand the mechanisms responsible for the resistance of cancers to treatment and to develop strategies to overcome these resistances. We are using molecular and cellular techniques and mouse models to potentiate the activity of radiation on tumors by inhibiting the bone marrow rescue of the tumor vasculature following therapy.
-
Axel Brunger
Professor of Molecular and Cellular Physiology, of Neurology, of Photon Science and, by courtesy, of Structural Biology
Current Research and Scholarly InterestsOne of Axel Brunger's major goals is to decipher the molecular mechanisms of synaptic neurotransmitter release by conducting imaging and single-molecule/particle reconstitution experiments, combined with near-atomic resolution structural studies of the synaptic vesicle fusion machinery.
-
Paul Buckmaster, DVM, PhD
Professor of Comparative Medicine and of Neurology
Current Research and Scholarly InterestsMechanisms of epilepsy, especially temporal lobe epilepsy.
-
Marion S. Buckwalter, MD, PhD
Professor of Neurology and of Neurosurgery
Current Research and Scholarly InterestsThe goal of the Buckwalter Lab is to improve how people recover after a stroke. We use basic and clinical research to understand the cells, proteins, and genes that lead to successful recovery of function, and also how complications develop that impact quality of life after stroke. Ongoing projects are focused on understanding how inflammatory responses are regulated after a stroke and how they affect short-term brain injury and long term outcomes like dementia and depression.
-
Felix Chang, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Felix Chang's clinical practice mainly involves intraoperative neurophysiologic monitoring (IONM) and the treatment of neurological disorders with botulinum toxin. He earned his medical degree at the University of Texas Southwestern Medical Center. He completed his neurology residency at the Harvard Neurology Program at the Beth Israel Deaconess Medical Center in Boston. He then went on to complete a fellowship in clinical neurophysiology with a focus in intraoperative neurophysiologic monitoring at Stanford.
-
Steven D. Chang, MD
Robert C. and Jeannette Powell Neurosciences Professor and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) and of Neurology
Current Research and Scholarly InterestsClinical research includes studies in the treatment of cerebrovascular disorders, such as aneurysms and AVMs, as well as the use of radiosurgery to treat tumors and vascular malformations of the brain and spine.
Dr. Chang is C0-Director of the Cyberknife Radiosurgery Program.
Dr. Chang is also the head of the The Stanford Neuromolecular Innovation Program with the goal of developing new technologies to improve the diagnosis and treatment of patients affected by neurological conditions. -
S. Charles Cho, MD
Clinical Professor, Neurology & Neurological Sciences
Current Research and Scholarly InterestsClinical research focused on peripheral nerve and muscle disorders. Also involved with prevention of cerebrovascular disesase in the intraoperative setting. Ongoing clincial studies include treatments for Amyotrophic Lateral Sclerosis (ALS), Inflammatory Demyelinating Neuropathy and HIV neuropathic pain.
-
Robert P. Cowan, MD, FAAN, FAHS
Clinical Professor, Neurology & Neurological Sciences
Clinical Professor (By courtesy), Anesthesiology, Perioperative and Pain MedicineCurrent Research and Scholarly InterestsCurrent interest focus on patient education technology and patient/physician communication with a particular emphasis on tools which increase encounter efficiency and improve outcomes. Basic research focuses on mechanisms of action in Chronic Daily Headache, with a particular emphasis on New Daily Persistent Headache. Techniques include fMRI, biomarker investigation and evoked potentials. Clinical research includes clinical trials of novel treatments for episodic and chronic headache forms.
-
John W. Day, MD, PhD
Professor of Neurology, of Pediatrics (Genetics) and, by courtesy, of Pathology
Current Research and Scholarly InterestsOur Neuromuscular Division coordinates a comprehensive effort to conquer peripheral nerve and muscle disorders, including the muscular dystrophies, motor neuron disorders, neuromuscular junction abnormalities, and peripheral neuropathies. With patients and families foremost in mind, we have had success defining and combating these diseases, with research focused on identifying genetic causes, developing novel treatment, and maximizing patient function by optimizing current management.
-
Jun Ding
Associate Professor of Neurosurgery and of Neurology
Current Research and Scholarly InterestsNeural circuits of movement control in health and movement disorders
-
Les Dorfman, MD
Professor of Neurology and Neurological Sciences, Emeritus
Current Research and Scholarly InterestsClinical electrophysiology of the peripheral and central nervous systems, including nerve conduction velocity; electromyography (EMG); and visual, auditory and somatosensory evoked potentials. Multiple sclerosis (MS) diagnosis and treatment. Neurological education.
-
Dawn Duane
Clinical Professor, Neurology & Neurological Sciences
Clinical Associate Professor, PediatricsCurrent Research and Scholarly InterestsI am a general pediatric neurologist. My interest is in clinical diagnosis and treatment of common neurologic diseases in pediatric patients and teaching feature doctors, neurologists and pediatric neurologists about pediatric neurology.
-
Shefali Dujari, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Dujari is a board-certified neurologist and fellowship-trained neurohospitalist, specializing in the care of acute neurologic disorders. She practices at both Stanford Hospital and Stanford ValleyCare. She completed her medical training at Boston University, internal medicine preliminary year at California Pacific Medical Center, neurology residency at Stanford University, and neurohospitalist fellowship at Stanford University. She serves as the Neurology Resident & Fellow Wellness & Mentoring Committee faculty lead, the associated program director of the Stanford Neurohospitalist Fellowship, and the physician lead of the ValleyCare Neuroscience Quality Committee. She has a special interest in medical education and quality improvement.
For more information on the Stanford Neurohospitalist Program & Fellowship, please visit: https://med.stanford.edu/neurology/divisions/neurohospitalist.html -
Jeffrey Dunn, MD
Clinical Professor, Neurology & Neurological Sciences
Current Research and Scholarly InterestsTranslational research in the human application of emerging immunotherapies for neurological disease, focusing on Multiple Sclerosis, CIS, transverse myelitis and Neuromyelitis Optica (NMO). Collaborative research with Stanford and extramural scientific faculty to identify biomarkers of disease activity and treatment response in humans. Clinical trials to assess efficacy of emerging treatments for MS, CIS and NMO.
-
Emmanuel During, MD
Clinical Associate Professor, Neurology & Neurological Sciences
Current Research and Scholarly InterestsImproving diagnostics and therapeutics in RBD, using home ambulatory devices including wearable actigraphy, dry-EEG, to power clinical trials based on objective outcomes of RBD activity.
Controlling symptoms of RBD testing drugs rigorously.
Predicting the course of neurodegeneration using deep phenotyping using clinical and serum biomarkers, measures of autonomic impairment, skin biopsy, microbiome -
Margaret S. Ferris, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Ferris is a fellowship-trained neurologist and Clinical Assistant Professor in the Department of Neurology, Division of Movement Disorders.
She diagnoses and treats a breath of movement disorders such as Parkinson’s disease and essential tremor. She recognizes the broad effects of these conditions on daily living and aims to develop personalized, comprehensive treatment plans that optimize health and quality of life.
Dr. Ferris research interests focus on access to interventional therapies for movement disorders. She has participated in investigations sponsored by the National Institutes of to evaluate advanced treatments for complications of Parkinson’s disease.
She has co-authored articles in publications such as Nature, The Neurohospitalist, and BioMed Central (BMC) Genomics. She has presented her insights about innovations in the understanding, detection, and management of movement disorders at conferences including, the Society for Neuroscience Annual Meeting, Pan American Parkinson’s Disease and Movement Disorders Congress.
She is a member of the American Academy of Neurology and the Movement Disorder Society. -
Anna Finley Caulfield, MD
Clinical Associate Professor, Neurology & Neurological Sciences
Current Research and Scholarly InterestsDr. Finley joined the Stanford Stroke Center in 2004 from Beth Israel Deaconess Medical Center in Boston. She cares for acute stroke patients and other neurologically critical ill patients in the intensive care unit. Currently, her research interests include hypothermia after cardiac arrest and comparing health care provider's predications of future neurological function in neurologically critical ill patients to their 6-month outcome.
-
Paul Graham Fisher, MD
Beirne Family Professor of Pediatric Neuro-Oncology, Professor of Pediatrics and, by courtesy, of Neurosurgery and of Epidemiology and Population Health
Current Research and Scholarly InterestsClinical neuro-oncology: My research explores the epidemiology, natural history, and disease patterns of brain tumors in childhood, as well as prospective clinical trials for treating these neoplasms. Research interests also include neurologic effects of cancer and its therapies, and childhood headaches.
-
Robert Fisher, MD, PhD
The Maslah Saul, MD, Professor and Professor, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsDr. Fisher is interested in clincal, laboratory and translational aspects of epilepsy research. Prior work has included: electrical deep brain stimulation for epilepsy, studied in laboratory models and clinical trials; drug delivery to a seizure focus; mechanisms of absence epilepsy studied with in vitro slices of brain thalamus; hyperthermic seizures; diagnosis and treatment of non-epileptic seizures, the post-ictal state; driving and epilepsy; new antiepileptic drugs; surgery for epilepsy.
-
Paul George, MD, PhD
Assistant Professor of Neurology and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsCONDUCTIVE POLYMER SCAFFOLDS FOR STEM CELL-ENHANCED STROKE RECOVERY:
We focus on developing conductive polymers for stem cell applications. We have created a microfabricated, polymeric system that can continuously interact with its biological environment. This interactive polymer platform allows modifications of the recovery environment to determine essential repair mechanisms. Recent work studies the effect of electrical stimulation on neural stem cells seeded on the conductive scaffold and the pathways by which it enhances stroke recovery Further understanding the combined effect of electrical stimulation and stem cells in augmenting neural repair for clinical translational is a major focus of this research going forward.
BIOPOLYMER SYSTEMS FOR NEURAL RECOVERY AND STEM CELL MODULATION:
The George lab develops biomaterials to improve neural recovery in the peripheral and central nervous systems. By controlled release of drugs and molecules through biomaterials we can study the temporal effect of these neurotrophic factors on neural recovery and engineer drug delivery systems to enhance regenerative effects. By identifying the critical mechanisms for stroke and neural recovery, we are able to develop polymeric technologies for clinical translation in nerve regeneration and stroke recovery. Recent work utilizing these novel conductive polymers to differentiate stem cells for therapeutic and drug discovery applications.
APPLYING ENGINEERING TECHNIQUES TO DETERMINE BIOMARKERS FOR STROKE DIAGNOSTICS:
The ability to create diagnostic assays and techniques enables us to understand biological systems more completely and improve clinical management. Previous work utilized mass spectroscopy proteomics to find a simple serum biomarker for TIAs (a warning sign of stroke). Our study discovered a novel candidate marker, platelet basic protein. Current studies are underway to identify further candidate biomarkers using transcriptome analysis. More accurate diagnosis will allow for aggressive therapies to prevent subsequent strokes. -
Carl Gold
Clinical Associate Professor, Neurology & Neurological Sciences
Clinical Associate Professor (By courtesy), NeurosurgeryBioDr. Gold is a board-certified neurologist who is fellowship-trained in the diagnosis and treatment of neurological disorders in hospitalized patients. He cares for a broad range of patients, including individuals with seizures, central nervous system infections, autoimmune diseases, headaches, neuromuscular conditions, and neurological complications of cancer. Dr. Gold's primary research interest focuses on enhancing the communication skills of neurology residents, and he serves as the Director of the Stanford Neurology Residency Communication Coaching Program. He is also the Fellowship Director of the Stanford Neurohospitalist Fellowship.
Dr. Gold serves as Vice Chair of Quality, Safety, & Experience for the Department of Neurology & Neurological Sciences. In this role, he coordinates projects aimed at improving care for patients with neurological conditions across the health system.
For more information on the Stanford Neurohospitalist Program & Fellowship, please visit: https://med.stanford.edu/neurology/divisions/neurohospitalist.html
Learn more about the Stanford Neurology Communication Coaching Program by visiting: http://med.stanford.edu/neurology/education/resident-coaching.html
Additional information on Stanford Neurology's efforts in Quality, Safety, & Value can be found here: http://med.stanford.edu/neurology/quality.html -
Olga Fedin Goldberg
Clinical Associate Professor, Neurology & Neurological Sciences
BioDr. Goldberg is board-certified in Neurology by the American Board of Psychiatry and Neurology. She provides comprehensive neurologic care to patients with a broad range of neurologic conditions, including those who have multiple neurologic conditions. She is interested in medical education for neurology residents and for referring primary care providers and serves as Director of Neurology Resident Continuity Clinic. Additionally, she completed the Stanford CELT (Clinical Education Leadership Training) Program for developing skills in quality improvement. She has led or played a key role in multiple quality improvement projects in the Department of Neurology, including those focused on increasing patient understanding of their neurologic medications upon hospital discharge, improvement of outcomes for headache patients seen in primary care, and in optimizing clinic processes involved in collection of cerebrospinal fluid.
-
Neelam Goyal, MD
Clinical Associate Professor, Neurology & Neurological Sciences
Current Research and Scholarly InterestsDr. Goyal specializes in the diagnosis, management, and electrophysiological testing of neuromuscular disorder (including SFEMG), with expertise in immune-mediated disorders (myositis, myasthenia gravis, CIDP, and vasculitis) and ALS. Her research interest include monitoring and managing toxicity of immunosuppressive agents. She is co-director of the MDA clinic, and provides botulinum toxin for treatment of sialorrhea for ALS patients.
-
Maxwell Greene, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Greene is a board-certified, fellowship-trained neurologist. He is also a Clinical Assistant Professor of Neurology at Stanford University School of Medicine.
Dr. Greene provides clinical care for adult patients with disorders of the muscles and peripheral nerves that cause weakness and numbness. He specializes in diagnosing and treating neuromuscular diseases that include amyotrophic lateral sclerosis (ALS), all types of muscular dystrophy, chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, and Charcot-Marie-Tooth (CMT). For CIDP and CMT, Stanford is one of the few centers of excellence in the country.
A significant part of Dr. Greene’s practice involves investigational work, where he seeks to determine the cause of a patient’s symptoms. In addition to performing the full range of diagnostic tests including interpreting biopsy procedures, he has special qualifications in electrodiagnosis and the use of electromyography and nerve conduction studies.
Treatments offered by Dr. Greene cover the complete spectrum of options, with an emphasis on immune therapies for certain conditions. For CIDP and myasthenia gravis, he administers immune globulin, steroids, plasmapheresis, and rituximab. To help manage symptoms of CMT and support areas of the body weakened by this disease, he can recommend physical therapy, occupational therapy, and foot, ankle, and knee orthotics.
For the treatment of ALS and muscular dystrophy, Dr. Greene leads a multidisciplinary team offering physical and occupational therapy, pulmonary expertise, speech and swallow expertise, nutrition counseling, social services, and specialized nursing, and works together with genetic counseling. All team members collaborate closely to ensure patients receive the care and comfort needed to meet their emotional as well as physical needs.
As part of his commitment to advancing patients’ treatment options, Dr. Greene conducts clinical research. Among his current interests are
innovative new therapies for ALS and other nerve and muscular disorders. This is an exciting time in the field of neuromuscular medicine, with real potential for treatment breakthroughs for the first time in decades. Exploring these new directions enables Dr. Greene to offer Stanford patients access to options that may not be available anywhere else.
To highlight new advances for his peers, Dr. Greene has made national and regional presentations at conferences including the American Academy of Neurology meeting. Topics include the results of a study supported in part by the National Institutes of Health: paraneoplastic antibodies as markers of Hodgkin’s disease. JAMA Neurology published Dr. Greene’s article on this research.
Dr. Greene’s achievements have earned recognition from the American Academy of Neurology and other organizations. He is also the recipient of a travel award from the American Neurological Association and a grant from the NIH National Institute of Neurological Disorders and Stroke.
A member of the American Academy of Neurology, Dr. Greene is also an active member of the Western ALS Consortium and Northeastern ALS Consortium. -
Michael Greicius, MD, MPH
Iqbal Farrukh and Asad Jamal Professor and Professor, by courtesy, of Psychiatry and Behavioral Sciences (Administrative and Academic Special Programs)
Current Research and Scholarly InterestsAs the Medical Director of the Stanford Center for Memory Disorders and Principal Investigator of the Stanford Extreme Phenotypes in Alzheimer's Disease (StEP AD) Cohort, Dr. Greicius' research focuses on elucidating the neurobiologic underpinnings of AD. His lab combines cutting edge brain imaging, "deep" phenotyping, and whole-genome sequencing of human subjects to identify novel pathways involved in AD pathogenesis. The goal of his work is to develop effective treatment for AD patients.
-
Jin S. Hahn, MD
Professor of Neurology at the Stanford University Medical Center, Emeritus
Current Research and Scholarly Interests1. Clinical informatics and electronic health records
2. Neonatal and fetal neurology
3. Prenatal diagnosis neurodevelopmental anomalies
4. Personalized Health and Wellness Records -
May Han, MD
Associate Professor of Neurology
Current Research and Scholarly InterestsMultiple sclerosis
Neuromyelitis optica
Autoimmune CNS disorders -
Melanie Hayden Gephart
Professor of Neurosurgery and, by courtesy, of Neurology
BioI am a brain tumor neurosurgeon, treating patients with primary and metastatic brain tumors. I treat patients with malignant and benign tumors, including glioma, brain metastases, meningioma, and vestibular schwannomas. I direct the Stanford Brain Tumor Center and the Stanford Brain Metastasis Consortium, collaborative unions of physicians and scientists looking to improve our understanding and treatment of brain tumors. My laboratory seeks greater understanding of the mechanisms driving tumorigenesis and disease progression in malignant brain tumors. We study how rare cancer cell populations survive and migrate in the brain, inadvertently supported by native brain cells. We develop novel cell free nucleic acid biomarkers to track brain cancer treatment response, relapse, and neurotoxicity. Our bedside-to-bench-to-bedside research model builds on a foundation of generously donated patient samples, where we test mechanisms of brain cancer growth, develop novel pre-clinical models that reliably recapitulate the human disease, and facilitate clinical trials of new treatments for patients with brain cancer.
www.GephartLab.com
www.GBMseq.org
https://stan.md/BrainMets
@HaydenGephartMD -
Zihuai He
Assistant Professor (Research) of Neurology and of Medicine (BMIR)
Current Research and Scholarly InterestsStatistical genetics and other omics to study Alzheimer's disease.
-
Jaimie Henderson, MD
John and Jene Blume - Robert and Ruth Halperin Professor, Professor of Neurosurgery and, by courtesy, of Neurology
Current Research and Scholarly InterestsMy research interests encompass several areas of stereotactic and functional neurosurgery, including frameless stereotactic approaches for therapy delivery to deep brain nuclei; cortical physiology and its relationship to normal and pathological movement; brain-computer interfaces; and the development of novel neuromodulatory techniques for the treatment of movement disorders, epilepsy, pain, and other neurological diseases.
-
Victor W. Henderson, MD, MS
Professor of Epidemiology and Population Health and of Neurology
Current Research and Scholarly InterestsResearch interests:
(1) Risk factors for age-associated cognitive decline and for dementia.
(2) Therapeutic strategies to improve cognitive abilities in aging and in dementia.
(3) Brain–behavior relations as they pertain to human cognition. -
Karen G. Hirsch, MD
Associate Professor of Neurology and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsDr. Karen G. Hirsch cares for critically ill patients with neurologic disorders in the intensive care unit. Dr. Hirsch's research focuses on using continuous and discrete multi-modal data to develop phenotypes and identify signatures of treatment responsiveness in patients with coma after cardiac arrest. She is the Co-PI of PRECICECAP (PRecision Care In Cardiac ArrEst - ICECAP, NINDS R01 NS119825-01) and works closely with collaborators in data science at Stanford and with industry partners to apply machine learning analyses to the complex multi-modal ICU data. Dr. Hirsch also studies neuro-imaging in post-cardiac arrest coma and traumatic brain injury.
Additional research interests include a broad array of topics and Dr. Hirsch greatly appreciates the importance of team science and collaboration. Along with colleagues in Biomedical Ethics, Dr. Hirsch studies brain death and organ donation with a focus on ethical challenges and prediction models. Along with colleagues in Cardiac Anesthesia and Cardiothoracic Surgery, Dr. Hirsch studies neurologic outcomes in patients on mechanical circulatory support including ECMO.
Dr. Hirsch is broadly interested in improving neurologic outcomes after acute brain injury and identifying early phenotypes to guide precision medicine in neurocritical care, especially in patients with post-cardiac arrest brain injury. -
John Hotson
Professor (Clinical) of Neurology and Neurological Sciences, Emeritus
Current Research and Scholarly InterestsThe response and recovery of human visual cortex, oculomotor systems and related cognitive functions after acquired neurological disorders is a main area of interest.
-
Ting-Ting Huang
Associate Professor (Research) of Neurology
Current Research and Scholarly InterestsWe study the role of oxygen free radicals in oxidative tissue damage and degeneration. Our research tools include transgenic and knockout mice and tissue culture cells for in vitro gene expression.
-
John Huguenard
Professor of Neurology and, by courtesy, of Molecular and Cellular Physiology
Current Research and Scholarly InterestsWe are interested in the neuronal mechanisms that underlie synchronous oscillatory activity in the thalamus, cortex and the massively interconnected thalamocortical system. Such oscillations are related to cognitive processes, normal sleep activities and certain forms of epilepsy. Our approach is an analysis of the discrete components (cells, synapses, microcircuits) that make up thalamic and cortical circuits, and reconstitution of components into in silico computational networks.
-
Michelle L. James
Assistant Professor of Radiology (Molecular Imaging Program at Stanford) and of Neurology
Instructor, Radiology- Molecular Imaging Program at StanfordCurrent Research and Scholarly InterestsThe primary aim of my lab is to improve the diagnosis and treatment of brain diseases by developing translational molecular imaging agents for visualizing neuroimmune interactions underlying conditions such as Alzheimer’s disease, multiple sclerosis, and stroke.
-
Safwan Jaradeh, MD
Professor of Neurology and, by courtesy, of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsClinical interests include autonomic disorders, small fiber neuropathies and the development of effective methods of testing and treating these disorders. Prior work has focused on small fiber painful and autonomic neuropathies; syndromes of orthostatic intolerance and syncope; gastrointestinal motility dysfunction; cyclic vomiting; protacted Gastroesophageal Reflux; non-allergic rhinitis syndromes; and the relationship between the autonomic nervous system and normal or abnormal sleep. Additional areas of interest include the neurology of phonation and swallowing disorders, and peripheral nerve injury and repair.
-
Susy Jeng
Clinical Associate Professor, Neurology & Neurological Sciences
Clinical Associate Professor, PediatricsBioDr. Susy Jeng is Clinical Associate Professor of Neurology at Stanford Children’s Hospital at Stanford University. Dr. Jeng received her A.B. at Harvard College and M.D. at the University of California, San Diego. She completed her pediatrics residency at University of California, San Francisco and is board-certified in pediatrics. After practicing general pediatrics for two years, she returned to UCSF for neurology residency. Upon completion of her residencies, she joined the faculty at Stanford as a general child neurologist with a special interest in medical education. She is the site director for the Stanford medical student neurology clerkship and the pediatric neurology liaison to the Stanford pediatrics residency program.
-
Maya Katz, MD
Clinical Associate Professor, Neurology & Neurological Sciences
BioDr. Katz is a board-certified neurologist who specializes in the treatment of Parkinson’s disease and other movement disorders. She is also a clinical associate professor of neurology at Stanford University School of Medicine.
In her clinical practice, she develops a comprehensive, compassionate treatment plan for every patient in her care. She excels at deep brain stimulation, neuromodulation, and other advanced treatment approaches. She also works closely with each patient’s caregivers and family members to help ensure optimal well-being and quality of life for all involved in the management of Parkinson’s disease, Huntington’s disease, Lewy body dementia, progressive supranuclear palsy, and other conditions.
Her research activities include serving as a co-investigator of the Parkinson’s Progression Markers Initiative funded by the Michael J. Fox Foundation. She is a site principal investigator for a National Institutes of Health-funded study of the application of palliative care to Parkinson’s disease. Previously, she was a co-investigator for studies of remote access to care for Parkinson’s disease and patient-centered outcomes in Parkinson’s disease, both funded by the National Parkinson Foundation.
Dr. Katz has earned many honors, including the ”Advancing Parkinson’s Therapies” conference award from the Parkinson’s Foundation and the “Fostering New Directions in Research” award from the Movement Disorders Society. She won scholarships from Weill Cornell Medical College, the Joseph Collins Foundation, and Anna E. Ray Robinson Education Fund.
She has presented her research findings at global meetings such as the International Parkinson and Movement Disorders Society and the International Palliative Care Society. She also has made presentations at national meetings of the American Academy of Neurology as well as regional conferences.
She has authored numerous articles on the topics of outpatient palliative care for Parkinson’s disease, caregiver burden in Parkinson’s disease, virtual visits for Parkinson’s disease, and diagnosis of cervical dystonia. Her work has appeared in journals including Neurology, Annals of Palliative Medicine, Contemporary Clinical Trials, Movement Disorders Clinical Practice, and Neurotherapeutics.
In addition, she is a reviewer for JAMA Neurology, the Journal of Neurological Sciences, Journal of Parkinson’s Disease, the brain imaging and stimulation section of Frontiers in Human Neuroscience, and Parkinsonism and Related
Disorders.
Dr. Katz is a member of the American Academy of Neurology, International Parkinson and Movement Disorders Society, Parkinson’s Foundation, Parkinson’s Study Group, American Academy of Hospice and Palliative Medicine, and American Telemedicine Association. She also is an invited speaker at community support groups for people with Parkinson’s disease. -
Lucas Kipp
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Kipp specializes in the diagnosis and treatment of neuroimmunological disorders, particularly demyelinating conditions such as multiple sclerosis and neuromyelitis optica. He is interested in translational research connecting expert MS clinicians, world-renown immunology laboratories, and advanced neuroimaging techniques to identify biomarkers of disease and treatment response.
-
Hannah Louise Kirsch, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioHannah Louise Kirsch, MD is a board-certified neurologist and a Clinical Assistant Professor in the Neurocritical Care Division of the Department of Neurology & Neurological Sciences at Stanford University School of Medicine.
Dr. Kirsch is also a hospitalist who pays special attention to delivering Stanford Health Care patients the best possible neurological care.
She serves on the National Institute of Neurological Disorders and Stroke committee dedicated to coma and conditions related to consciousness. She has implemented numerous neurology-centered educational activities for health care professionals from diverse specialties, including training psychiatrists on the neuropsychiatric complications of COVID-19. She also has helped educate oncologists and hematologists regarding common neurological conditions among cancer patients.
Dr. Kirsch has conducted research on a range of topics, including thrombotic complications in critically ill COVID-19 patients, advances in intracranial pressure monitoring, and predictors of outcomes in acute encephalitis. She has published her findings in Neurology, the Journal of Trauma, Emergency Medicine, and Procedures, among other journals.
She has given presentations on topics including variations in coagulation among patients with cerebral hemorrhage and the association of cerebral pressure with cardiac arrest. She has shared her discoveries at meetings of the Neurocritical Care Society and Society of Hospital Medicine.
The Neurocritical Care Society has honored her work. She also won the prestigious Leonard Tow Humanism in Medicine Award, which recognizes clinical excellence, outstanding compassion in the delivery of care, and respect for patients, families, and health care colleagues.
Dr. Kirsch received her medical degree from New York University. She completed her residency in neurology at the University of California, San Francisco, and a fellowship in neurocritical care at Columbia University. She also completed the Columbia University narrative medicine certificate program and is board certified in neurology by the American Board of Psychiatry and Neurology. -
Juliet Klasing Knowles
Assistant Professor of Neurology and of Pediatrics
Current Research and Scholarly InterestsThe Knowles lab studies how white matter structure changes in different forms of epilepsy, and how aberrant white matter structure, in turn, shapes neuronal network function. In mouse models, we use a variety of innovative tools including neurophysiology, quantitative EEG, behavior, histological measures of white matter structure and MR imaging. We also conduct clinical research to study white matter abnormalities in children with epilepsy.
-
Lironn Kraler, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Kraler is a board-certified neurologist with subspecialty training in vascular neurology, and a Clinical Assistant Professor at Stanford University School of Medicine. Dr. Kraler is also the Associate Program Director for the Vascular Neurology Fellowship at Stanford.
Before joining the faculty at Stanford, Dr. Kraler attended medical school at Keck School of Medicine at the University of Southern California where she was elected to the Alpha Omega Alpha National Honor Society. She completed her residency training at Stanford Hospital where she served as chief resident, followed by her Vascular Neurology fellowship training at Stanford. She then completed a post-doctoral research fellowship at Stanford University’s Clinical Excellence Research Center (CERC) focused on addressing the high cost of care in US Hospitals.
Her research interests include improving access and quality of population health and developing high-value innovations in care delivery that decrease the cost of care while improving the quality to patients. In addition, she has a strong interest in medical education. Dr. Kraler has received recognition for outstanding medical student teaching from the Department of Neurology. -
Prashanth Krishnamohan, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
Clinical Assistant Professor (By courtesy), NeurosurgeryBioDr. Krishnamohan is a board-certified, fellowship-trained neurologist. He is a clinical assistant professor of neurology and neurological sciences and, by courtesy, of neurosurgery at Stanford University School of Medicine. In addition, he is Medical Director of the Neurosciences Service Line at Stanford Health Care – ValleyCare and is Medical Director of its Stroke program.
Dr. Krishnamohan excels in the diagnosis and treatment of neurological conditions. His clinical interests include the management of stroke, epilepsy, concussion, and coma. With every patient, his goal is to provide personalized care designed to optimize neurological function for the best possible clinical outcome and quality of life.
He has published extensively on topics including innovations in stroke care quality management and measurement, rapid bedside evaluation of seizures in the ICU, and EEG metrics in comatose cardiac arrest patients. Articles by Dr. Krishnamohan have appeared in Neuroanesthesia and Neurocritical Care, Quality Management in Healthcare, Current Infectious Disease Reports, and other journals. He has presented his research findings at the annual meetings of the Neurocritical Care Society and American Academy of Neurology.
He has authored chapters on post-concussive syndrome, stroke, and other conditions for the guidebook Ferri’s Clinical Advisor. In addition, he is a reviewer for the Journal of Neuroscience Nursing, Neurohospitalist, and the Journal of Neurology, Neurosurgery, and Psychiatry.
Dr. Krishnamohan has won recognition from Stanford Health Care, the Institute for Healthcare Improvement Open School, the University of Kentucky College of Medicine, and PSG Institute of Medical Sciences and Research – the latter two his alma maters.
Dr. Krishnamohan is a member of the Neurocritical Care Society, American Academy of Neurology, and American Heart Association/American Stroke Association. He volunteers as a community health educator with numerous organizations. -
Kathryn Kvam
Clinical Associate Professor, Neurology & Neurological Sciences
Clinical Associate Professor (By courtesy), NeurosurgeryCurrent Research and Scholarly InterestsDr. Kvam's research focuses on 1) how to measure quality of care for patients with neurologic disease, 2) the value and impact of neurohospitalist models of care on patient outcomes and trainee education and 3) outcomes in rare diseases like autoimmune encephalitis.
-
Maarten Lansberg, MD, PhD
Professor of Neurology and, by courtesy, of Neurosurgery
On Partial Leave from 08/22/2022 To 02/21/2023Current Research and Scholarly InterestsMy research involves the design and conduct of clinical trials to discover new treatments for patients who have suffered a stroke. These trials span treatment of acute stroke, stroke recovery, and stroke prevention. My research in acute stroke is primarily focused on the use of advanced neuroimaging methods (CT and MRI) to select patients who are most likely to benefit from therapies aimed at restoring blood flow to the brain in patients who have suffered a stroke.
-
Nicholas Wiessner Larsen, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Larsen is a clinical assistant professor in the Department of Neurology, Division of Autonomic Disorders. He is a board-certified neurologist and a fellowship-trained specialist in neurophysiology and autonomics. He completed medical school at the University of Utah and neurology residency and fellowship at Stanford.
In his clinical practice, Dr. Larsen focuses on disorders of the autonomic nervous system (ANS). His research interest is in the long-term autonomic complications of COVID-19. He is the principal investigator of a study looking at post-COVID postural tachycardia syndrome.
Dr. Larsen’s research interests also include Global Health Neurology. Dr. Larsen helped establish the first stroke unit in Rwanda and is part of the American Academy of Neurology’s Refugees & Asylum Seekers Working Group.
He has co-authored articles for publication in Clinical Autonomic Research, Autonomic Neuroscience, Nature Climate Change, and elsewhere. He is a recipient of the American Academy of Neurology Medical Student Prize for Excellence as well as a member of the Alpha Omega Alpha Honor Medical Society. -
Amira Latif Hernandez
Instructor, Neurology & Neurological Sciences
BioAmira obtained her Ph.D. in Neuroscience from the KU Leuven, Belgium, in summer 2017. During her doctoral studies, she used clinically valid tests of murine cognition, neuronal plasticity measures in hippocampal and cortical slices, brain lesion methods, pharmacological applications and resting state functional magnetic resonance imaging to characterize the pathophysiology of novel mouse models of Alzheimer’s disease (AD). One of her most gratifying contributions was the development of a new electrophysiology tool to assess synaptopathies, and the establishment of long-term synaptic plasticity from prefrontal cortex of APP knock-in mice. In Autumn 2017, she moved to Dr. Longo’s lab at the Stanford School of Medicine, where she investigates signaling pathways involved in synaptic degeneration. During 3 years of postdoctoral work, she established a multi-electrode array system with eight independent recording chambers that allows high-throughput analyses of multiple long-lasting forms of synaptic plasticity. She also gained experience in RNA-sequencing, molecular biochemistry, signaling mechanisms, target validation and drug development strategies for AD. In October 2020, Amira has been appointed as an Instructor in Neurodegenerative Disease Research, in the Longo lab, to help develop improved and more powerful approaches that will better reveal key synaptic mechanisms and candidate modules associated with neuroplasticity and affected in AD mouse models, by identifying activity-dependent gene expression signatures.
-
Scheherazade Le, MD
Clinical Associate Professor, Neurology & Neurological Sciences
Current Research and Scholarly InterestsNeurophysiology, Epilepsy/EEG, Intraoperative Neurophysiologic Monitoring,Tuberous Sclerosis, Autoimmune Epilepsy/Encephalitis
-
Jin Hyung Lee
Associate Professor of Neurology, of Neurosurgery and of Bioengineering and, by courtesy, of Electrical Engineering
Current Research and Scholarly InterestsIn vivo visualization and control of neural circuits
-
Christopher Lee-Messer, MD, PhD
Clinical Assistant Professor, Neurology & Neurological Sciences
Clinical Associate Professor, Neurology & Neurological SciencesCurrent Research and Scholarly InterestsMy chief clinical focus is in pediatric epilepsy, especially how epilepsy affects learning and development. For my research, I background in neural development and computational neuroscience towards developing better learning algorithms and applying the latest techniques in machine learning for better diagnosis and treatment of disease.
-
Kenneth Leung, MD, MS
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Leung is a board-certified neurologist who practices both comprehensive neurology and neuromuscular medicine. He is a Clinical Assistant Professor in the Department of Neurology within the Stanford University School of Medicine.
Dr. Leung has a particular interest in the diagnosis and management of a broad range of disorders affecting muscle and nerves, including motor neuron disease, neuropathy, neuromuscular junction disorders, and myopathy. He also is an avid clinician educator who develops course work, is involved in education research, and teaches medical students and neurology residents/fellows. He currently serves as Director of the Neurology Clerkship for medical students within the Stanford University School of Medicine.
He earned his bachelor’s degree from the University of California, Berkeley where he was awarded the 2011 Departmental Citation Award for Excellence in Research in Immunology. In 2016 he earned his medical degree and concurrent master’s degree in applied anatomy from Case Western Reserve University School of Medicine. He then completed his internal medicine internship at Santa Clara Valley Medical Center and neurology residency at the Mount Sinai Hospital in New York. During this time, he developed a passion for neurology education and served on graduate medical education committees for curricular development, trainee well-being and resilience, and quality improvement. For his work in medical education, he was selected as a Harvard Macy Institute Scholar in 2018 and was awarded the 2020 Institute for Medical Education House Staff Excellence in Teaching Award. He was also inducted as a house staff in the Alpha Omega Alpha honor society. He then went on to complete a neuromuscular medicine fellowship at Stanford prior to joining as faculty.- -
Gordon Li, MD
Professor of Neurosurgery and, by courtesy, of Neurology and of Otolaryngology - Head & Neck Surgery (OHNS)
Current Research and Scholarly Interests1.) My laboratory studies the biology of brain tumors with the goal of developing novel therapeutics for the treatment of malignant brain tumors and translating that research into clinical trials.
2.) My clinical interests include improving surgical techniques for brain tumor surgery, immunotherapy for the treatment of glioblastoma, and novel uses for stereotactic radiosurgery. -
Yi Li, MD, PhD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Li is a board-certified, fellowship-trained neurologist and a clinical assistant professor in the Department of Neurology and Neurological Sciences at Stanford University School of Medicine.
She specializes in epilepsy care and research. She has dedicated her career to advancing our understanding of the mechanism, diagnosis, and treatment of epilepsy. In addition to her MD degree, she holds a PhD degree in neurology and neuroscience. She undertook PhD training to better understand epileptogenesis and to identify potential new treatments for refractory epilepsy patients. She has received the Stanford Genetics and Genomics Certificate, which helped advance her knowledge of how genomic data can enhance patient management in clinical practice.
She has published numerous articles on a wide range of epilepsy-related topics. Among her honors, Dr. Li has earned recognition from the American Epilepsy Society and International League Against Epilepsy. She also won a safety and quality awards scholarship from the American Academy of Neurology. She is a member of the American Academy of Neurology and the American Epilepsy Society. -
Y. Joyce Liao, MD, PhD
Professor of Ophthalmology and of Neurology
Current Research and Scholarly InterestsIschemic optic neuropathy
Stem cell transplantation
Optic neuropathy
Optic neuritis
Eye movement disorders
Reading
Parkinson's disease
Multiple sclerosis -
Michael Lim, M.D.
Professor of Neurosurgery and, by courtesy, of Radiation Oncology (Radiation Therapy), of Medicine (Oncology), of Otolaryngology - Head & Neck Surgery (OHNS) and of Neurology
BioDr. Lim is the Chair of the Department of Neurosurgery and a board-certified neurosurgeon specializing in brain tumors and trigeminal neuralgia.
Dr. Lim’s clinical interests include the treatment of benign and malignant brain tumors, with special interest in gliomas, meningiomas, metastatic tumors, and skull base tumors. Dr. Lim also specializes in surgical treatments for trigeminal neuralgia. During his time at Johns Hopkins, Dr. Lim built one of the largest brain tumor and trigeminal neuralgia practices and utilized the most advanced surgical technologies and techniques for his patients. As a passionate voice for patient experience, he has been recognized by his peers and patients for his integrity and compassionate care, including a Service Excellence Award from HealthNetwork Foundation.
As a mentor, he has garnered numerous teaching awards, including being honored as an outstanding teacher by Johns Hopkins University School of Medicine. He is actively involved in shaping education for neurosurgery and oncology across the United States and around the world.
Dr. Lim’s research interests focus on harnessing the immune system to fight cancer. His laboratory focuses on understanding mechanisms of immune evasion by cancer cells. He has successfully translated his findings from the laboratory to the clinics and has conducted and led several large national immunotherapy clinical trials for brain tumors.
Dr. Lim’s bibliography contains well over 200 articles on topics such as immunotherapy for glioblastoma, long-term survival of glioma patients treated with stereotactic radiation, and treatment of neuropathic pain. His work has appeared in Science Translational Medicine, Clinical Cancer Research, Lancet Oncology, Nature Immunology, and many more publications. He also has written 20 book chapters and monographs.
Dr. Lim is a world leader in immunotherapy for brain tumors. In addition to being invited world-wide to give lectures and seminars, he has given platform presentations on the topics of immunotherapy for brain tumors, neurosurgical techniques and management of brain tumors at the American Society of Clinical Oncologists, American Academy of Neurological Surgeons, Radiological Society of North America, Annual Symposium on Brain and Spine Metastases, Congress of Neurological Surgeons, and other meetings. In addition, he has served as platform chairman of the CNS session at the American Society for Clinical Oncology conference.
Dr. Lim is a member of the American Society for Clinical Oncology, Congress of Neurological Surgeons, American Association of Neurological Surgeons, and Society for Neuro-Oncology. Dr. Lim served as the program co-chair of the Society for Neuro-Oncology and CNS section of the American Society for Clinical Oncology. He also served on many executive committees, including the Executive Committee for the Joint Tumor Section of the American Association of Neurological Surgeons and Congress of Neurological Surgeons. -
Kathie S Lin
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Lin practices both Neuromuscular Medicine and Comprehensive Neurology in Emeryville and Palo Alto. She has a particular interest in the diagnosis and management of neuromuscular disease including neuromuscular junction disorders, motor neuron disease, and focal neuropathy. Additionally, she is interested in medical education and developing a practical framework for teaching neurology and neurophysiology to medical students and neurology residents.
She earned her medical degree at the University of Pittsburgh School of Medicine where was awarded a Dean's Scholarship and the Dr. Tryphena Humphrey Student Award in Neurology. She completed neurology residency at the Harvard Neurology Program at the Beth Israel Deaconess Medical Center in Boston where she served as an administrative chief resident in her final year and was awarded the Michael Ronthal Resident Teaching Award. She then went on to complete her neuromuscular medicine fellowship at Stanford. -
Frank M. Longo, MD, PhD
George E. and Lucy Becker Professor of Medicine and Professor, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsClinical interests include Alzheimer's disease and Huntington's disease and the development of effective therapeutics for these disorders. Laboratory interests encompass the elucidation of signaling mechanisms relevant to neurodegenerative disorders and the development of novel small molecule approaches for the treatment of neurodegenerative and other neurological disorders.
-
Jaime Lopez, MD
Professor of Neurology and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsMy clinical interests are in the areas of Intraoperative Neurophysiologic Monitoring (IOM), clinical neurophysiology, electromyopgraphy and in the use of botulinum toxins in the treatment of neurologic disorders. Our IOM groups research is in the development of new and innovative techniques for monitoring the nervous system during surgical and endovascular procedures and how these alter surgical management and patient outcomes. I am also active in formulating national IOM practice guidelines.
-
Sean Mackey, M.D., Ph.D.
Redlich Professor, Professor of Anesthesiology, Perioperative, and Pain Medicine and, by courtesy, of Neurology
Current Research and Scholarly InterestsMultiple NIH funded projects to characterize CNS mechanisms of human pain. Comparative effectiveness of cognitive behavioral therapy and chronic pain self-management within the context of opioid reduction (PCORI funded). Single session pain catastrophizing treatment: comparative efficacy & mechanisms (NIH R01). Development and implementation of an open-source learning healthcare system, CHOIR (http://choir/stanford.edu), to optimize pain care and innovative research in real-world patients.
-
William J Marks
Adjunct Clinical Professor, Neurology & Neurological Sciences
BioDr. Marks received an Honors Bachelor of Science degree in Biology from Marquette University and his Medical Degree from the Johns Hopkins University School of Medicine. He completed his neurology residency and fellowship at the University of California, San Francisco (UCSF). Dr. Marks also holds a Master of Science in Health Care Management degree from the Harvard School of Public Health.
Dr. Marks is Board Certified in Neurology and Clinical Neurophysiology. Prior to joining the Stanford Faculty, he served as Professor of Neurology at UCSF. His clinical and research interests include movement disorders, epilepsy, neuromodulation, health technology, and health care policy.
Dr. Marks also serves as Head of Clinical Neurology at Verily Life Sciences, formerly Google Life Sciences—a translational research and engineering organization focused on improving healthcare by applying scientific and technological advances to significant problems in health and biology. At Verily, Dr. Marks is responsible for developing and implementing strategies and initiatives that will advance the understanding of neurological disorders to ultimately improve patient outcomes. -
Jamie McDonald, MD, MS
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. McDonald is a fellowship-trained, board-certified neurologist and clinical assistant professor in the Department of Neurology at Stanford University School of Medicine.
She specializes in the diagnosis and treatment of multiple sclerosis and other demyelinating diseases, including neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody disease (MOGAD). Dr. McDonald also provides comprehensive care to general neurology patients.
Dr. McDonald completed her internship and adult neurology residency at the University of Utah. She has a long-standing interest in multiple sclerosis care and went on to complete a two-year clinical MS/neuroimmunology fellowship at Stanford Health Care Multiple Sclerosis Center. Dr. McDonald received the National MS Society’s Sylvia Lawry Physician Fellowship, including formalized training in conducting clinical trials. As part of her fellowship, she completed a master’s degree in epidemiology and clinical research. -
Steven Lee Mcintire
Clinical Associate Professor, Neurology & Neurological Sciences
BioDr. McIntire earned his MD from Harvard Medical School and his PhD in Neuroscience from Harvard University, where he was awarded a Frank Knox Memorial Fellowship and Carl Walter Fellowship. He then completed Neurology residency training at UCSF. He is board certified in Neurology by the American Board of Psychiatry and Neurology. He has been named a Robert Ebert Clinical Scholar and Culpepper Medical Science Scholar. Dr. McIntire has published extensively in the fields of molecular neurobiology and neurogenetics.
Dr. McIntire’s interests are in general/comprehensive neurology. He is also interested in medical education and the training of medical students and neurology residents. -
Kimford Meador, MD
Professor of Neurology
BioDr. Meador is a Professor of Neurology and Neurosciences at Stanford University, and Clinical Director, Stanford Comprehensive Epilepsy Center. Dr. Meador graduated from the Georgia Institute of Technology in Applied Biology (with high honor) and received his MD from the Medical College of Georgia. After an internship at the University of Virginia and service as an officer in the Public Health Corps, he completed a residency in Neurology at the Medical College of Georgia and a fellowship in Behavioral Neurology at the University of Florida. Dr. Meador joined the faculty at the Medical College of Georgia (1984-2002) where he became the Charbonnier Professor of Neurology. He was the Chair of Neurology at Georgetown University (2002-2004), the Melvin Greer Professor of Neurology and Neuroscience at the University of Florida (2004-2008) where he served as Director of Epilepsy Program and Director of the Clinical Alzheimer Research Program, and Professor of Neurology and Pediatrics at Emory University (2008-2013) where he served as Director of Epilepsy and of Clinical Neurocience Research. He joined the faculty of Stanford University in 2013. Dr. Meador has authored over 400 peer-reviewed publications. His research interests include: cognitive mechanisms (e.g., memory and attention); cerebral lateralization; pharmacology and physiology of cognition; mechanisms of perception, consciousness and memory; EEG; epilepsy; epilepsy and pregnancy; preoperative evaluation for epilepsy surgery; intracarotid amobarbital procedure (i.e., Wada test); functional imaging; therapeutic drug trials; neurodevelopmental effects of antiepileptic drugs; psychoimmunology; behavioral disorders (e.g., aphasia, neglect, dementia); and neuropsychiatric disorders. Dr. Meador has served as the PI for a long running NIH multicenter study of pregnancy outcomes in women with epilepsy and their children. Dr. Meador has served on the editorial boards for Clinical Neurophysiology, Epilepsy and Behavior, Epilepsy Currents, Journal of Clinical Neurophysiology, Neurology, Cognitive and Behavioral Neurology, and Epilepsy.com. His honors include Resident Teaching Award Medical College of Georgia; Outstanding Young Faculty Award in Clinical Sciences Medical College of Georgia; Distinguished Faculty Award for Clinical Research Medical College of Georgia Lawrence C. McHenry History Award American Academy of Neurology; Dreifuss Abstract Award American Epilepsy Society; Fellow of the American Neurological Association; Diplomat of American Neurologic Association; past Chair of the Section of Behavioral Neurology of American Academy of Neurology; past President of Society for Cognitive and Behavioral Neurology; past President of the Society for Behavioral & Cognitive Neurology; past President of the Southern EEG & Epilepsy Society; ranking in the top 10 experts in epilepsy worldwide by Expertscape; Distinguished Alumnus Award for Professional Achievement, Medical College of Georgia, Georgia Regents University 2015; American Epilepsy Society Clinical Research Award; and named award by the American Epilepsy Society: “Kimford J. Meador Research in Women with Epilepsy Award,” and ranked in the top 500 neuroscientist in the world and top 300 in USA by Research.com in 2022.
-
Vinod Menon
Rachael L. and Walter F. Nichols, MD, Professor and Professor, by courtesy, of Education and of Neurology
Current Research and Scholarly InterestsEXPERIMENTAL, CLINICAL AND THEORETICAL SYSTEMS NEUROSCIENCE
Cognitive neuroscience; Systems neuroscience; Cognitive development; Psychiatric neuroscience; Functional brain imaging; Dynamical basis of brain function; Nonlinear dynamics of neural systems. -
Mitchell Miglis, MD
Clinical Associate Professor, Neurology & Neurological Sciences
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Sleep MedicineCurrent Research and Scholarly InterestsProdromal markers of neurodegeneration in REM sleep behavior disorder
Autonomic dysfunction in Long-COVID
Postural tachycardia syndrome -
Emmanuel Mignot, MD, PhD
Craig Reynolds Professor of Sleep Medicine and Professor, by courtesy, of Genetics and of Neurology
Current Research and Scholarly InterestsThe research focus of the laboratory is the study of sleep and sleep disorders such as narcolepsy and Kleine Levin syndrome. We also study the neurobiological and genetic basis of the EEG and develop new tools to study sleep using nocturnal polysomnography. Approaches mostly involve human genetic studies (GWAS, sequencing), EEG signal analysis, and immunology (as narcolepsy is an autoimmune disease of the brain).
-
Rebecca Kate Miller-Kuhlmann
Clinical Assistant Professor, Neurology & Neurological Sciences
Clinical Associate Professor, Neurology & Neurological SciencesBioRebecca Miller-Kuhlmann, MD is board certified in Neurology and in Electrodiagnostic Medicine and practices as a Clinical Assistant Professor of Neurology & Neurological Sciences at Stanford University. She earned her MD from UCSF School of Medicine and completed residency and fellowship training at Stanford University. Her fellowship training in Comprehensive Clinical Neurology focused on movement disorders, memory/cognitive disorders neuromuscular medicine/EMG/NCS studies, and therapeutic applications of botulinum toxin with supplementary training in headache, epilepsy and neuroimmunology. Her clinical focus is diagnosis and treatment of neurologic conditions with commitment to maintaining a wide-breadth of knowledge in order to best treat complex patients with multiple neurologic issues.
Academically, Dr Miller-Kuhlmann is passionate about medical education and physician wellbeing. Prior to her career in medicine, Dr Miller-Kuhlmann was a public school teacher in Oakland, CA. She completed the UCSF health professions education pathway with a dean's award for research in medical student reflection during medical school. During residency she served as education chief resident and earned an honors certificate in medical education at Stanford, She continues to enjoy working with medical students and residents in the clinic as well as the classroom. She associate-directs the Neurology Block for second year medical students and in 2020 has had the privilege to begin directing the Science of Medicine course which covers physiology and pathology of each organ system for first and second year medical students. At the residency level, she serves as the associate-director for a novel communication coaching program within the Stanford Neurology Residency.
Dr. Miller-Kuhlmann is the Wellbeing Director for the Department of Neurology and interested in multi-level strategies for promotion of professional fulfillment and mitigation of physician burnout. Nationally, she was an inaugural graduate of the American Academy of Neurology's Live Well Lead Well Leadership programs, serves on the AAN physician wellness subcommittee, and has had the opportunity to speak on physician wellbeing at the AAN annual meeting. Locally, she has co-developed and directs a wellbeing program for neurology residents and fellows, steers the neurology department wellness committee, and through close partnership with department quality improvement leaders serves on projects to improve physician wellbeing through a focus on system supports and efficiencies. To this end, she is also a graduate of the Stanford Clinical Effectiveness Leadership Program which develops skills in quality improvement and change management. She also co-developed and annually teaches a project-based novel quality improvement curriculum for residents with an eye toward empowering and supporting trainees in becoming agents of change within the system.
